Edit |   |
---|---|
Antigenic Specificity | RSV, Respiratory syncytial Virus (Motavizumab biosimilar) |
Clone | Motavizumab |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-RSV Recombinant Antibody (Motavizumab). Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009, it is undergoing Phase II and III clinical trials. |
Immunogen | n/a |
Other Names | Anti-RSV Recombinant Antibody, Research Grade Motavizumab, Anti-RSV Recombinant Antibody(Motavizumab), MEDI-524, Antibody Drug Analogues, Monoclonal Antibody, YR1031, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 677010-34-3 |
Catalog # | YR1031 |
Price | please inquire |
Order / More Info | RSV, Respiratory syncytial Virus (Motavizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |